Health

A phase III study has shown that the addition of an investigational anti-PD-1 drug to perioperative chemotherapy has resulted in improved event-free survival in patients with resectable, stage III non-small cell lung cancer (NSCLC). The study, called Neotorch, found that patients who received toripalimab had a greater benefit and higher rates of major pathologic response
Registry analyses have shown that transcatheter aortic valve replacement (TAVR) explantation carried the highest mortality risk for the rising number of patients needing aortic reintervention. The Society of Thoracic Surgeons (STS) data showed that the number of TAVR patients requiring a subsequent surgical valve (SAVR) grew significantly from 2011 to 2021. The number of patients
Two nationally representative surveys conducted in Australia reveal that doctors may be more neurotic than both patients and the general population. The surveys also compared the “Big Five” personality traits of doctors with those of patients and the general population. It was found that doctors were significantly more agreeable, conscientious, and extroverted than both the
The FDA has issued a safety communication, warning against the improper marketing of amniotic fluid eye drops for the treatment of dry eye disease. The communication links to earlier letters to two manufacturers – makers of Regener-Eyes and StimulEyes – warning that the products would need an approved Biologics License Application (BLA) to stay on
A recent study has found that the prevalence of stroke has remained stable among community-dwelling adults in the United States between 1999 and 2018. However, there has been a slight increase in self-reported stroke cases among men. The findings were based on data from the National Health and Nutrition Examination Survey (NHANES) and were published
In the past, primary care practices had crash carts that contained medications and equipment for advanced resuscitation in case of a medical emergency. However, the infrequency of such events made these carts unnecessary and they eventually became obsolete. Although patients in ambulatory primary care practices may require emergency care, having the capacity for advanced medical
An investigational drug called LX9211 could be the first-in-class treatment for post-herpetic neuralgia (PHN), a type of neuropathic pain that can occur after shingles. According to researcher Anand Patel, MD, of Conquest Research in Florida, the drug inhibits adapter protein 2-associated kinase-1 (AAK1), which is known to cause neuropathic pain. The drug performed well in